The rhythm of plasma melatonin concentration is currently the most accurate marker of the endogenous human circadian pacemaker. A number of methods exist to estimate circadian phase and amplitude from the observed melatonin rhythm. However, almost all of these methods are limited because they depend on the shape and amplitude of the melatonin pulse, which varies among individuals and can be affected by environmental influences, especially light. Furthermore, these methods are not based on the underlying known physiology of melatonin secretion and clearance, and therefore cannot accurately quantify changes in secretion and clearance observed under different experimental conditions. A published physiologically-based mathematical model of plasma melatonin can estimate synthesis onset and offset of melatonin under dim light conditions. We amended this model to include the known effect of melatonin suppression by ocular light exposure and to include a new compartment to model salivary melatonin concentration, which is widely used in clinical settings to determine circadian phase. This updated model has been incorporated into an existing mathematical model of the human circadian pacemaker and can be used to simulate experimental protocols under a number of conditions. " " DLMO 25% the data, which assumes that the shape of the melatonin pulse can be captured by a fundamental plus 2-harmonic (e.g., approximately 24, 12, and 8 hr) sinusoidal curve. Then, 25 of this fit amplitude is calculated and linear interpolation is used to estimate the time at which % the plasma melatonin concentration crosses this value. This time is used as the phase marker (see Fig. 3 
Introduction
The activity of the endogenous circadian pacemaker located in the suprachiasmatic nucleus (SCN) within the hypothalamus cannot be measured directly in humans. In order to extract information about circadian phase or amplitude or other characteristics of the circadian system, overt marker rhythms must be used. A comparison of the plasma melatonin rhythm to two other marker rhythms, core body temperature and cortisol, revealed that phase markers measured by melatonin were the least variable under relatively constant conditions, and therefore are more precise markers of the endogenous circadian rhythm ( ). Melatonin is also commonly used as a marker in circadian 1 rhythms research because it can be assayed in blood, saliva or urine and because it is relatively unaffected by sleep-wake state or changes in posture ( ). 2
Multiple mathematical methods have been published (for review, see ( ) and ( )) by which circadian phase can be extracted from the 2 1 plasma melatonin rhythm. Most of these methods depend on curve-fitting of the melatonin profile and/or the crossing of a threshold to determine phase. Thus, these methods assume certain characteristics about the shape and amplitude of the melatonin profile. For example, to calculate phase as the quarter crossing of the fit ( ), the amplitude of a melatonin pulse is calculated from a 3-harmonic fit of J Pineal Res. Author manuscript Page / 2 16 physiology. A second problem is that the error in the calculation is not reported. Some circadian rhythms experiments report phase shifts of as little as 30 minutes as significant. However, without knowledge of the error in the phase marker, the statistical significance of the results and the statistical power of the experiments may not be known.
The suppression of melatonin by ocular light exposure has been used to probe the sensitivity of the circadian pacemaker to light in blind persons ( ), to varying intensities and durations of polychromatic light exposure, and to long-term changes in light exposure ( ). This 7 4 method is appropriate because the pathway for ocular light suppression of melatonin begins in the retina, travels via the single-synaptic retino-hypothalamic tract (RHT) to the SCN of the hypothalamus, through the paraventricular nuclei (PVN) and the superior cervical ganglion (SCG) and ends in the pineal ( ). Intensity response curves ( ) demonstrate that the half-maximum sensitivity to light estimated 8 9 from plasma melatonin suppression occurs at approximately 100 lux, with maximum melatonin suppression occurring between 1000 and 10000 lux. For comparison, ordinary room light levels are approximately 100 lux; studies conducted in room light may inadvertently include melatonin suppression in addition to other specified experimental effects. More recent studies have also reported melatonin suppression by monochromatic light with peak sensitivity in the short-wavelength bands ( ) ( ) ( ) ( ). 10 11 12 13 In 1997, Brown et al. ( ) introduced a method for calculating melatonin phase and amplitude using a physiologically-based 14 differential equation model of the diurnal variation of plasma melatonin concentrations. Details of the model are included below, in the Methods section. This model can be used to estimate the onset ( ) and offset ( ) of plasma melatonin production, as well as the SynOn SynOff amount of melatonin secreted (amplitude). The onsets and offsets estimated by the model were comparable to assessments of melatonin phase based on threshold methods. This method also yields information about the infusion rates of melatonin into and clearance rates of melatonin out of the plasma, information that cannot be extracted using the other methods but that may be useful in understanding the physiology. A method to estimate melatonin phase that is based on physiology may be a much more useful tool for melatonin analysis because there are no intrinsic assumptions about the shape and amplitude of the melatonin pulse and because the parameters (e.g., synthesis onset and offset, infusion and clearance rates, amplitude) can be directly related to secretory processes. Such information may provide physiological insight into the differences in melatonin levels seen across individuals, and in different conditions.
Salivary melatonin rhythms have also been used as markers of the endogenous circadian pacemaker. Saliva samples for melatonin assay are often collected when it is impossible or impractical to collect plasma samples. Phase estimates are usually calculated by the same curve-fitting and threshold methods used for plasma melatonin. However, in addition to the problems detailed above for analyzing plasma samples for circadian information, there are at least two additional problems with using saliva for this purpose: (a) Salivary melatonin concentrations are ~30 lower than plasma melatonin concentrations ( ) which may make threshold methods even more difficult to % 15 apply and (b) often only the rising portion of the salivary melatonin pulse is collected, because most melatonin secretion occurs when an individual is asleep and therefore not available for producing saliva samples. The lack of data from the entire time of melatonin secretion makes it impossible to use any threshold calculation that depends on the overall amplitude of the pulse.
We developed two additions to the existing physiologically-based model of melatonin: (a) a photic effect to predict melatonin suppression by light and (b) a saliva compartment to predict salivary melatonin concentration. This model was then integrated with an existing mathematical model of the effect of light on the human circadian pacemaker ( ) and used to estimate melatonin synthesis onset 16
and offset, amplitude and infusion and clearance rates from data collected under a variety of conditions, including (a) a constant routine procedure (CR, described below); (b) exposures to continuous bright light, continuous dim light and intermittent bright light; and (c) conditions in which melatonin sampling rate was low or only included the rising portion of the melatonin curve. We compare these predictions to other known methods of melatonin phase estimation and discuss which methods are most accurate under a variety of experimental conditions.
Methods

Model Equations
The physiologically-based model of melatonin developed by Brown and colleagues ( ) was based on the physiological data of 14 melatonin synthesis, secretion and clearance from rats; it is assumed that the same or similar physiology exists for humans. The pathway for pineal melatonin synthesis includes the following steps: tryptophan is hydroxylated and then decarboxylated to form serotonin.
Arylalkylamine N-acetyltransferase (AANAT) converts serotonin to N-acetylserotonin ( ), which is then O-methylated by 17
hydroxindole-O-methyltransferase to produce melatonin ( ). Melatonin is not stored in the pineal, which is on the body side of the blood 18 brain barrier, and readily diffuses into the bloodstream ( ), where it is transported through the blood, partially bound to albumin ( ). The 19 20 hormone is cleared by the liver and excreted through the urine ( ). The mathematical model of this synthesis is a first-order kinetic 21 process with two compartments: the pineal compartment and the plasma compartment. These two compartments are represented by two first-order differential equations:
A physiologically-based mathematical model of melatonin J Pineal Res. Author manuscript Page / 3 16 where is the rate of infusion of melatonin into the plasma, is the rate of clearance of melatonin from the plasma, ( ) is the
concentration of melatonin in the pineal compartment and is the concentration of melatonin in the plasma. is the AANAT H (t) 2 A(t) activity at time t and is calculated by the following function:
where is the AANAT activity growth, is the AANAT activity decline, is the onset time of increased AANAT activity and is λ α t on t off the offset time of growth in AANAT activity and is the maximum AANAT activity (pmol l min ). Although the original model was A
based on the assumption that AANAT activity is the rate limiting step of melatonin synthesis, more recent studies indicate that this may not be the case Liu and Borjigin 2005 J. Pineal Research need to add to refman .
[ -]
Data Analysis
Several datasets were used to develop and test the additions to the physiologically-based model of melatonin. Fluorescent white light was used in all studies (see ( ) for details, including light spectrum). For all protocols, circadian phase was assessed during constant 22 routines (CRs) using a 2-harmonic plus noise fit of Core Body Temperature ( ) ( ) and melatonin as phase markers. During a CR, CBT min 23 individuals remain awake in bed under dim light with frequent small meals; the CR is designed to minimize changes known to affect markers of the circadian pacemaker ( )( ).
was used as the phase marker during the experiment to time events because CBT 24 25 CBT min data are available in real time and can be analyzed immediately, unlike melatonin which must first be assayed. A description of each dataset follows: (VDL) of <1 lux (n 7). In each condition, the stimulus was preceded and followed by 30 minutes of <1 lux. The stimulus day was = followed by a 64-hr CR. The light level during wakefulness was ~1.5 lux from the start of the initial CR until the end of the second CR, except during the light exposure session. Although the IBL stimulus represented only 23 of the total duration of the continuous light % exposure, the phase shift of , their marker of melatonin phase, during IBL exposure was 74 as great as during a CBL DLMO 25% % stimulus. Melatonin suppression was observed in the CBL and IBL conditions ( ), but was not reported in ( ). The data from this study 26 3 were used to introduce the effect of light in the pineal melatonin concentration equation ( ). The plasma melatonin Equation 1
Intermittent Bright Light (IBL) dataset
concentrations from the light exposure days were used to develop and test the addition of a light suppression effect to the melatonin model.
The plasma melatonin concentrations from the initial CR were used to determine the entrained phase angles between and CBT min SynOn and . SynOff
3-Pulse Phase-Resetting Protocol
Duffy et al. ( ) performed a series of experiments in which 31 subjects were scheduled to two 24.0-hr days in ~90 lux followed by a 27 26 to 33-hr CR, depending on the desired center of the bright light stimulus. After the initial CR, subjects were scheduled to 8 hr of sleep in 0 lux. During the following three wake episodes, subjects were exposed to a 5-hr ~9500 lux pulse centered in the middle of the 16-hr wake episode, which occurred at different circadian phases to either phase-advance or phase-delay the pacemaker. The 3-cycle bright light stimulus was followed by a 40-hr CR. CBT and plasma melatonin rhythms were assessed throughout the protocol. The light level during wakefulness was ~10 lux from the start of the initial CR until the end of the second CR, except during the bright light stimuli. The plasma melatonin concentrations from the initial CR were used to determine the entrained phase angles between and and . CBT min SynOn SynOff
1-Pulse Intensity Response Curve Protocol
Zeitzer et al. ( ) performed a series of experiments to determine the response of the pacemaker to light pulses of varying intensities. In 9 these experiments, 21 subjects were scheduled to two 24.0-hr days in 150 lux followed by a ~50-hr CR. After the initial CR, subjects were scheduled to 8 hr of sleep in 0 lux. During the following wake episode, subjects were randomly assigned to receive a single 6.5-hr light pulse centered ~3.5 hr before with intensities ranging from 3 lux to 9100 lux. The stimulus day was followed by a 30-hr CR. The CBT min A physiologically-based mathematical model of melatonin J Pineal Res. Author manuscript Page / 4 16 light level during wakefulness was ~10 lux from the start of the initial CR until the end of the second CR, except during the stimulus.
Melatonin suppression was calculated as the difference between the area under the curve (AUC) of the baseline melatonin pulse and the melatonin pulse during the light exposure divided by the baseline AUC. Baseline AUC was calculated from the 4-hr before the melatonin midpoint during the initial CR and the AUC during the light exposure was calculated using the same clock hours 24 hours later. AUC was calculated using the trapezoidal method. These data were used to validate the addition of a light suppression effect to the melatonin model.
Salivary Melatonin Concentration dataset
Both salivary and plasma samples were collected for melatonin assay from totally blind subjects scheduled to various inpatient protocols. The details of these protocols were described in Klerman et al. 1998 ( ) . Data from these totally blind subjects were not 28 confounded by ocular light suppression of melatonin concentrations. The salivary melatonin data were used to test and validate the addition of a salivary compartment to the melatonin model.
Incorporation of an effect of light on melatonin
Previous Model
In 
Bŵ here is a scaling constant and is the fraction of elements in the system that are used . Used elements are recycled back into the G n " " ready state at a rate of . In general, the rate at which elements are activated (processed from ready to used ) in Process L is given at any The drive generated in acts onto the dynamic circadian pacemaker, Process P. Process P is divided into two components: Equation 5
the circadian pacemaker and the circadian sensitivity modulator. The coupled pacemaker equations are and represent a higher-order limit cycle oscillator, and the coefficients in were chosen so that the amplitude Equations 7 8 Equation 7
of the limit cycle would equal 1.00, as in previous iterations of the model ( ). 29 enters Process P via the circadian sensitivity modulator, where it is converted into a direct drive, onto the pacemaker that is B̂B, dependent on the state variables and such that x x c to characterize the feature that the human circadian pacemaker has varying sensitivity to light throughout the circadian day ( ).
J Pineal Res. Author manuscript Page / 5 16 where is as described above, 0.97, and is defined as the polar phase angle between the state variables x and x such CBT min
Incorporation of light into melatonin model
To incorporate an effect of light into the melatonin model, the AANAT activity, , in was redefined as:
where is a constant whose value was determined by parameter fitting to the and validated on the m Intermittent Bright Light dataset .
1-Pulse Intensity Response Curve dataset
A phase relationship was derived to compare the results of the model to melatonin and CBT data in humans. and melatonin CBT min and were calculated from the initial CR data from the and the SynOn SynOff 3-Pulse Phase-Resetting Protocol Intermittent Bright Light . dataset
Parameter Fitting
Parameter fits to the data were derived by a similar method to the one described in the original publication ( ). The following 14 equation is used to relate the model predictions to plasma melatonin data:
where is the plasma melatonin level at time and is an approximate Gaussian random variable with mean 0 and variance H (t ) nalysis was used to calculate . This analysis was based on the counts per minute recorded from the immunoassay. These data were not available for this analysis, nor are they available for many clinical applications. Therefore, we derived from the intra-assay coefficient of variance obtained from the laboratory at which the melatonin immunoassays were run. the . A value of 7 was found to provide the best fit for all subjects. Intermittent Bright Light dataset m =
Saliva Compartment
The design of the saliva compartment was modeled by the same principles as the pineal and plasma compartments were created in the original mathematical model of melatonin. It is assumed that all melatonin is released from the pineal gland into the plasma ( ). In the J Pineal Res. Author manuscript Page / 6 16 plasma, melatonin partially binds to albumin and is eventually cleared through the liver. Melatonin that does not become bound to albumin readily diffuses into the saliva ( ). Melatonin in the saliva is eventually cleared through unknown processes. A third equation is added to 33 account for the infusion of melatonin from the plasma into the saliva compartment and for the clearance from saliva. This equation is:
where is the rate of infusion from the plasma to the saliva compartment and is the rate of clearance from the saliva. The plasma β IS β CS compartment equation ( ) has also been modified to include the infusion from the plasma to the saliva. This equation is: Equation 1
A schematic of the model including the saliva compartment is in . Fig. 1 
Comparison of Model Simulations to Data
To determine which model fit the experimental data better, both the adjusted R (R ) and the Akaike Information Criterion (AIC) increases to 8. For the salivary melatonin model ( ), two additional parameters were added to the model; therefore, k 10.
Equation 18
=
Results
For the 51 subjects from the and the , occurred 8. 26 For the VDL condition, the R values are approximately equal for both models, while the AIC increases for the model with the 2 incorporated light effect. Because the light level in this condition is low, the light suppression is not activated; the AIC values increase due to the 2k parameter penalty in the AIC equation.
" "
This model was validated by fitting the model to data from the with m 7 as found by fits 1-Pulse Intensity Response Curve Protocol = to the as described above. plots the melatonin suppression calculated from the model fits as a Intermittent Bright Light dataset Fig. 3 function of light intensity. The predicted melatonin suppression data for each subject were fit with a 4-parameter logistic function. The original experimental data reported in ( ) has been superimposed onto for comparison. Zeitzer et al. reported a half-maximal light 9 Fig. 3 intensity of 106 lux with saturation of the melatonin suppression response occurring at ~200 lux and minimal suppression occurring below 80 lux, with variable response between these two lux levels. Similarly, the model predicts a half-maximal response at 96 lux with saturation of the melatonin suppression response at ~200 lux.
The data from one blind subject from the are plotted in against model predictions. Salivary Melatonin Concentration dataset Fig. 4 reports the R , and for each subject in whom a full salivary melatonin profile was available. also reports Table 2 2 SynOn SynOff Table 2 the and values for each subject calculated from plasma melatonin, when available. In general, the AIC values are lower for SynOn SynOff the salivary than for plasma melatonin data. This does not indicate that the fits by the salivary melatonin model are better; the difference in values may be due to difference in sampling rates of saliva and plasma melatonin concentrations. The salivary melatonin data were also more variable than the plasma data, which may also explain why the R values are lower in the salivary melatonin fits. 2 When only a portion of a melatonin pulse is available for analysis, relative threshold methods such as cannot be used to DLMO 25% estimate circadian phase. Often under clinical settings, only the rising portion of a salivary melatonin pulse is obtained, because collecting samples throughout the night would require interrupting the sleep episode. Only the rising portion of the melatonin profile was analyzed for 14 melatonin profiles from 4 subjects in the These data were fit by the model to determine Salivary Melatonin Concentration dataset. 
The data from one subject are plotted in against model predictions. reports the R , AIC and for each subject in Fig. 5 Table 3 2 SynOn which the rising portion of the salivary melatonin concentration was available. In some cases, the value predicted was not a SynOn reasonable estimate of the true clock time at which would be estimated to occur based on other methods. The possible reasons for SynOn this include a poor fitting procedure, a bad choice of initial parameters, data that are too noisy, or not enough data points.
Another way to assess the model s ability to calculate when only the rising portion of a curve is available is to truncate full ' SynOn plasma and salivary melatonin curves and fit the model. A total of 16 full salivary melatonin curves were available for this analysis from the . The curves were truncated at the peak value of melatonin obtained. Again, an arbitrary Salivary Melatonin Concentration dataset , equal to the time at which the final available data point was measured, was used.
reports the R and the values SynOff Table 4 2 SynOn estimated from the truncated curves compared to the values estimated from the full curves. There is larger variability between the SynOn two values, which suggests that a full curve may be necessary to obtain an accurate .
SynOn SynOn
The existing mathematical model of the human circadian pacemaker uses as a phase marker of the circadian system, although CBT min the CBT rhythm itself is not an output of the model. By incorporating melatonin as both a phase marker and an output rhythm of the circadian pacemaker, the model can predict both phase and melatonin suppression.
is an example of the output of the melatonin Fig. 6 model generated by simulating the , as described above. The phase response to the light stimulus is 3-Pulse Phase-Resetting Protocol determined by subtracting initial phase found during the initial pre-stimulus CR from the final phase found during the post-stimulus CR.
Additionally, melatonin suppression is observed on the three light exposure days, which affects the estimate of melatonin phase. By incorporating melatonin into our existing model of the circadian pacemaker, the model can predict both melatonin phase and melatonin suppression under a number of experimental protocols.
Discussion
The original physiologically-based mathematical model of melatonin was able to estimate synthesis onset, offset and amplitude from plasma melatonin samples collected under dim light conditions. We have updated this model to include an effect of ocular light exposure.
This model can be used to estimate synthesis onset, offset and amplitude from plasma melatonin samples collected under a variety of lighting conditions, including exposure to intermittent bright light pulses. Phase estimates are often not calculated on light exposure days because threshold methods cannot account for the change in shape and amplitude of the melatonin profile that is observed during the light exposure. However, the model with an incorporated light effect can account for the changes in melatonin concentration observed in response to a light pulse. Furthermore, the additional parameters of the model, including infusion rate of melatonin into the plasma and clearance rate from the plasma, may provide useful information about the dynamics of melatonin suppression by light.
A physiologically-based mathematical model of melatonin J Pineal Res. Author manuscript Page / 8 16 We also added a salivary melatonin compartment to the existing model. The structure of the salivary melatonin compartment is similar to the plasma melatonin compartment and includes rates of infusion from the plasma to saliva and clearance from the saliva. Thus, this model can be used to estimate synthesis onset, offset and amplitude from salivary melatonin samples when plasma melatonin samples have not been collected. Because full salivary melatonin profiles are not always available, we additionally tested whether the model was able to predict accurately the synthesis onset from the rising portion of salivary melatonin only. As can be seen in , the results of this Table 4 analysis were inconclusive: for some melatonin pulses analyzed, the estimates obtained from the rising portion of the curve were SynOn within 2 minutes of the estimates obtained from the full curve. For other melatonin pulses, this was not the case. Further analysis SynOn with a larger set of data is necessary. The updated melatonin model was incorporated into an existing model of the circadian pacemaker.
The original model of the circadian pacemaker reported as the phase marker; however, melatonin is the preferred marker rhythm CBT min and most experimental results are reported using melatonin. Therefore, the addition of this melatonin model to the circadian pacemaker model facilitates comparisons of experimental results to model predictions. Additionally, melatonin suppression by light is often used to evaluate the sensitivity of the pacemaker to varying durations, timings and intensities of light. This model of the circadian pacemaker can predict melatonin suppression as well as phase shifts of the melatonin rhythm.
In the original publication of the melatonin model ( ), it was reported that estimates of synthesis onset and offset were comparable to 14 melatonin phase markers estimated by threshold methods. Because existing threshold methods depend on the shape and amplitude of the melatonin pulse, they are not adequate measures to estimate phase under experimental conditions in which the shape and amplitude of the melatonin profiles changes. We propose that a physiologically-based method to estimate melatonin phase is more appropriate because these changes in shape and amplitude are considered in the parameters of the model. Furthermore, this method of analysis can provide additional information about the melatonin profile that cannot be measured with threshold-based methods.
Many studies have shown that melatonin suppression by light ( ) ( ) ( ) ( ), as well as circadian phase-shifting measured from 10 11 12 13 the melatonin rhythm ( ) ( ) ( ) ( ), is differentially sensitive to light wavelength. In particular, action spectra that have been 12 35 36 37 constructed from melatonin suppression data reveal peak sensitivity around 460 nm ( ) ( ) Future work on the circadian model will 10 11 include the incorporation of wavelength of light information to predict the effect of narrowband and broadband monochromatic light stimuli on melatonin suppression and melatonin phase shifts.
A user-friendly version of the model detailed in this paper is available for download at: or http://dsm.bwh.harvard.edu/bmu/melatonin/ can be obtained directly from the author. 
Fig. 2
The melatonin concentration of a subject exposed to a 6.5-hr continuous bright light (CBL) pulse (top panel, ~9500 lux), six 15-min intermittent bright light (IBL) pulses during a 6.5 hour interval (middle panel, ~9500 lux pulses separated by 60-min of <1 lux) and a 6. ------------indicates that data were missing or that an accurate value could not be obtained.
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Table 3
Estimates of the model with an incorporated salivary melatonin component to the rising portion of the salivary melatonin concentration. 
Subject
